Detalhe da pesquisa
1.
Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.
Eur J Haematol
; 110(1): 67-76, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193973
2.
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.
Am J Hematol
; 98(2): 290-299, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588398
3.
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.
Am J Hematol
; 96(6): 719-726, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784434
4.
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
Haematologica
; 103(5): 799-809, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439183
5.
Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.
Am J Hematol
; 92(10): E567-E574, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699225
6.
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
Blood
; 123(25): 3951-62, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24778155
7.
Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy.
Am J Hematol
; 91(12): 1239-1245, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27643573
8.
The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia.
Br J Haematol
; 181(1): 137-139, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220937
9.
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin.
Haematologica
; 97(2): 219-26, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21993666
10.
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia.
Cells
; 12(1)2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611797
11.
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily.
Haematologica
; 96(1): 163-6, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20934998
12.
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML.
Am J Hematol
; 86(7): 533-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21538470
13.
Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes.
Am J Cancer Res
; 11(3): 955-967, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791166
14.
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
Blood Adv
; 4(20): 5118-5132, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085758
15.
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.
EBioMedicine
; 50: 111-121, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31761618
16.
Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.
Neoplasia
; 20(6): 632-642, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29772458
17.
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.
Oncotarget
; 8(14): 23061-23072, 2017 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416739
18.
Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation.
Oncotarget
; 7(29): 46466-46481, 2016 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27341131
19.
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.
Clin Cancer Res
; 22(8): 2051-61, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26607600
20.
Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.
Am J Cancer Res
; 5(1): 354-62, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628944